PF-05402536
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-05402536, covering 2016-01-26 to 2016-01-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers. [Phase 1]